Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, N1G 2W1, Canada.
Toxicol Appl Pharmacol. 2013 Jul 15;270(2):129-38. doi: 10.1016/j.taap.2013.04.013. Epub 2013 Apr 26.
Bilirubin (BR) has recently been identified as the first endogenous substrate for cytochrome P450 2A5 (CYP2A5) and it has been suggested that CYP2A5 plays a major role in BR clearance as an alternative mechanism to BR conjugation by uridine-diphosphate glucuronyltransferase 1A1. This study investigated the mechanisms of Cyp2a5 gene regulation by BR and the cytoprotective role of CYP2A5 in BR hepatotoxicity. BR induced CYP2A5 expression at the mRNA and protein levels in a dose-dependent manner in primary mouse hepatocytes. BR treatment also caused nuclear translocation of Nuclear factor-E2 p45-related factor 2 (Nrf2) in hepatocytes. In reporter assays, BR treatment of primary hepatocytes transfected with a Cyp2a5 promoter-luciferase reporter construct resulted in a 2-fold induction of Cyp2a5 reporter activity. Furthermore, cotransfection of the hepatocytes with a Nrf2 expression vector without BR treatment resulted in an increase in Cyp2a5 reporter activity of approximately 2-fold and BR treatment of Nrf2 cotransfectants further increased reporter activity by 4-fold. In addition, site-directed mutation of the ARE in the reporter construct completely abolished both the BR- and Nrf2-mediated increases in reporter activity. The cytoprotective role of CYP2A5 against BR-mediated apoptosis was also examined in Hepa 1-6 cells that lack endogenous CYP2A5. Transient overexpression of CYP2A5 partially blocked BR-induced caspase-3 cleavage in Hepa 1-6 cells. Furthermore, in vitro degradation of BR was increased by microsomes from Hepa 1-6 cells overexpressing CYP2A5 compared to control cells transfected with an empty vector. Collectively, these results suggest that Nrf2-mediated CYP2A5 transactivation in response to BR may provide an additional mechanism for adaptive cytoprotection against BR hepatotoxicity.
胆红素 (BR) 最近被确定为细胞色素 P450 2A5 (CYP2A5) 的第一个内源性底物,并且已经表明 CYP2A5 在 BR 清除中作为 BR 结合的替代机制发挥主要作用通过尿苷二磷酸葡糖醛酸基转移酶 1A1。本研究探讨了 BR 对 Cyp2a5 基因调控的机制以及 CYP2A5 在 BR 肝毒性中的细胞保护作用。BR 以剂量依赖的方式在原代小鼠肝细胞中诱导 CYP2A5 在 mRNA 和蛋白质水平上的表达。BR 处理还导致核因子-E2 p45 相关因子 2 (Nrf2) 在肝细胞中的核易位。在报告基因测定中,用 Cyp2a5 启动子-荧光素酶报告基因构建体转染的原代肝细胞中的 BR 处理导致 Cyp2a5 报告基因活性增加 2 倍。此外,在用 BR 处理之前共转染肝细胞中的 Nrf2 表达载体导致 Cyp2a5 报告基因活性增加约 2 倍,并且 BR 处理 Nrf2 共转染物使报告基因活性进一步增加 4 倍。此外,报告基因构建体中 ARE 的定点突变完全消除了 BR 和 Nrf2 介导的报告基因活性的增加。还在缺乏内源性 CYP2A5 的 Hepa 1-6 细胞中检查了 CYP2A5 对 BR 介导的细胞凋亡的细胞保护作用。在 Hepa 1-6 细胞中转瞬表达 CYP2A5 部分阻断了 BR 诱导的 caspase-3 切割。此外,与对照细胞相比,用空载体转染的 Hepa 1-6 细胞中 BR 的体外降解增加了用 CYP2A5 过表达的 Hepa 1-6 细胞的微粒体。总之,这些结果表明,BR 响应 Nrf2 介导的 CYP2A5 反式激活可能为针对 BR 肝毒性的适应性细胞保护提供了另一种机制。